Influence of formulation technology on theophylline release from chitosan-based pellets
Authors:
K. Dvořáčková; G. Škrabáková; M. Rabišková
Authors place of work:
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků
Published in the journal:
Čes. slov. Farm., 2009; 58, 216-224
Category:
Původní práce
Summary
Pellets containing theophylline, microcrystalline cellulose and chitosan were prepared by wetting with chitosan solution (1–5%) in 10% acetic acid using the extrusion/ spheronization method. The influence of chitosan content (0.98–4.47 %) on theophylline release from pellets was studied and their dissolution profiles were compared with the results obtained in pellets without chitosan and pellets containing 25% of chitosan prepared by wetting with acetic acid. A slower theophylline release (up to 5 hrs) at pH 6.8 from pellets prepared with chitosan solution was found; it was caused probably by the interaction of the carbonyl groups of MCC and the amino groups of chitosan forming a polyionic complex. A prolonged release of the drug was maintained also at pH 1.2, when chitosan dissolves. For the interaction with MCC and prolonged drug liberation it was necessary to use chitosan in the form of a solution.
Key words:
chitosan – microcrystalline cellulose – theophylline – pellets – extrusion/spheronization
Zdroje
1. Dukić-Ott, A., Thommes, M., Remon, J. P. et al.: Eur. J. Pharm. Biopharm., 2009; 71, 38–46.
2. Janovská, L., Škrabáková, G., Vetchý, D. et al.: Čes. a slov. Farm., 2009; 58, 21–27.
3. Tapia, C., Buckton, G., Newton, J. M.: Int. J. Pharm., 1993; 92, 211–218.
4. Miyazaki, S., Ishii, K., Nadai, T.: Chem. Pharm. Bull., 1981; 29, 3067–3069.
5. Miyazaki, S., Yamaguchi, H., Yokouchi, C. et al.: Chem. Pharm. Bull., 1988; 36, 4033–4038.
6. Takayama, K., Hirata, M., Machida, Y. et al.: Chem. Pharm. Bull., 1990; 38, 1993–1997.
7. Shiraishi, S., Arahira, M., Imai T. et al.: Chem. Pharm. Bull., 1990; 38, 185–187.
8. Knapczyk, J.: Int. J. Pharm. 1993; 89, 1–7.
9. Kumar, M. N. V. R.: Reactive & functional polymers, 2000; 46, 1–27.
10. Sawayangi, Y., Nambu, N., Nagai, T.: Chem. Pharm. Bull., 1982; 30, 4464–4467.
11. Shirashi, S., Arahira, M., Imai, T. et al.: Chem. Pharm. Bull., 1990; 38, 185–187.
12. Illum, L.: Pharm. Res., 1998; 15, 1326–1331.
13. Ritthidej, G. C., Chomto, S., Pummangura, S. et al.: Drug Dev. Ind. Pharm., 1994; 20, 2109–2134.
14. Säkkinen, M.: Biopharmaceutical Evaluation of Microcrystalline Chitosan as Release-Rate-Controlling Hydrophilic Polymer in Granules for Gastro-Retentive Drug Delivery, Academic Disertation, Helsinki 2003.
15. Upadrashta, S. M., Katikaneni, P. R., Nuessle, N. O.: Drug Dev. Ind. Pharm. 1990; 18, 1701–1708.
16. Dodane, V., Vilivalam, V. D.: Pharm. Sci. Technol. Today, 1998; 4, 246–253.
17. Henriksen, I., Green, K. L., Smart, J. D. et al.: Int. J. Pharm., 1996; 145, 231–240.
18. Takeuchi, H., Yamamoto, H., Niwa, T. et al.: Pharm. Res., 1996; 13, 896–901.
19. Shimono, N., Takatori, T., Ueda, M. et al: Int. J.Pharm., 2002; 254, 45–54.
20. Muzzarelli, R. A. A.: Cell Mol. Life Sci., 1997; 53, 131–140.
21. Steckel, H., Minderman-Nogly, F.: Eur. J. Pharm. Biopharm., 2004; 57, 107–114.
22. Sinha, V. R., Singla, A. K., Wadhawan, S. et al: Int. J. Pharm., 2004; 247, 1–33.
23. Nunthanid, J., Laungtana-anan, M., Srimornsak, P. et al.: J. Controlled Rel., 2004; 99, 15–26.
24. Chandy, T., Sharma, Ch. P.: Biomaterials, 1993; 14, 939–944.
25. Umemura, K., Kawai, S.: Carbohydrate Polymers, 2007; 68, 242–248.
26. Chung, Y., Kuo, Ch., Chen, Ch.: Bioresource Technology, 2005; 96,1473–1482.
27. Gällstedt, M.: Films and composites based on chitosan, wheat gluten or wheat proteins – their packaging related to mechanical and barrier properties. Stockholm: KTH Royal Institut of Technology, Academic dissertation 2004.
28. Hokosawa, J., Nishiyama, M., Yoshihara, K. et al: Industrial & Engeneering Chemistry Research, 1991; 30, 788–792.
29. Svoboda, J.: Organická chemie I. 1. vydání. Praha: Vysoká škola chemicko-technologická 2005; 226–227.
30. Mi, F. L., Shyu, S. S., Wong, S. F. et al.: J. Controlled Release, 1997; 44, 19–32.
31. Ruel-Gariepy, E., Chenite, A., Chaput, C. et al: Int. J. Pharm., 2000; 203, 89–98.
32. Shu, X. Y., Zhu, K. J., Song, W.: Int. J. Pharm, 2001; 212, 19–28.
33. Berger, J., Reist, R., Mayer, J. M. et al.: Eur. J. Pharm. Biopharm., 2004; 57, 19–34.
34. Charoenthai, N., Kleinebudde, P., Puttipipatkhachorn, S.: AAPS PharmSciTech, 2007; 8, 64.
35. Takahashi, T., Takayama, K., Machida, Y. et al.: Int. J. Pharm., 1990; 61, 35–41.
36. Surini, S., Akiyama, H., Morishita, M. et al.: J. Controlled Rel., 2003; 90, 291–301.
37. Hiorth, M., Versland, T., Heikkil, J. et al.: Int. J. Pharm., 2005; 308, 25–32.
38. Puttipipatkhachorn, S., Nunthanid, J., Yamamoto, K. et al.: J. Controlled Rel., 2001; 75, 143–151.
39. Asada, M., Takahashi, H., Okamoto, H. et al.: Int. J. Pharm., 2004; 270, 167–174.
40. Boonsogrit, Y., Mitrejev, A., Mueller, B. W.: Eur. J. Pharm. Biopharm., 2006; 62, 267–274.
41. Gryczová, E., Dvořáčková, K., Rabišková, M.: Čes. a slov. Farm. 2009; 58, 9–13.
42. Rabišková, M., Häring, A., Minczingerová, K. et al.: Chem. Listy, 2007; 101, 70–77.
43. Moore, J. W., Flanner, H. H.: Pharm. Tech., 1996; 20, 64–74.
44. Lu, Ch., Lu, Y., Chen, J. et. al.: Eur. J. Pharm. Biopharm., 2007; 66, 210–219.
45. Costa, P., Lobo, J. M. S.: Eur. J. Pharm. Sci., 2001; 13, 123–133.
46. Avachat A., Kotwal, V.: AAPS PharmSciTech, 2007; 8, 88.
47. Colombo, P., Bettini, R., Peppas, N. A.: J. Controlled Release, 1999; 61, 83–91.
48. Hayashi, T., Kanbe, H., Okada, M. et al.: Int. J. Pharm., 2005; 304, 91–101.
49. Deasy, P. B., Law, M. F. L.: Int. J. Pharm., 1997; 148, 201–209.
50. Vertommen J., Kinget R.: Drug Dev. Ind. Pharm., 1997; 23, 39–46.
51. Santos, H., Veiga, F., Pina, M. et al.: Int. J. Pharm., 2002; 246, 153–169.
52. Okada, S., Nahahara, H., Isaka, H.: Chem. Pharm. Bull., 1987; 35, 761–768.
53. Rivera, S. L., Ghodbane, S.: Int. J. Pharm., 1994; 108, 31–38.
54. Al-Nimry, S. S., Assaf, S. M., Jalal, I. M. et al.: Int. J. Pharm., 1997; 149, 115–121.
55. Sung-Hyun, P., Myung-Kwan, Ch., Hoo-Kyun, Ch.: Int. J. Pharm., 2008; 347, 39–44.
Štítky
Farmacie FarmakologieČlánek vyšel v časopise
Česká a slovenská farmacie
2009 Číslo 5-6
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Infekce se v Americe po příjezdu Kolumba šířily nesrovnatelně déle, než se traduje
Nejčtenější v tomto čísle
- Metody přípravy mikročástic ve farmaceutické technologii
- Příspěvek k vývoji reklamy ve farmacii I
- Sledování vybraných jakostních parametrů parenterální výživy AIO – pilotní studie
- Vliv technologie přípravy na uvolňování theofylinu z pelet s chitosanem